Lv5
812 积分 2022-07-15 加入
Sequential osteoanabolic therapy for osteoporosis
4天前
已完结
Sequential and combination therapy with romosozumab
4天前
已完结
Impact of prior teriparatide treatment on the effectiveness of romosozumab in patients with postmenopausal osteoporosis: A case-control study
4天前
已完结
Therapy with transitions from one bone-forming agent to another: a retrospective cohort study on teriparatide and romosozumab
4天前
已完结
Efficacy and safety of denosumab biosimilar CMAB807 versus Prolia® in Chinese postmenopausal women with osteoporosis
18天前
已完结
Population pharmacokinetic/pharmacodynamic model of LY06006 in Chinese healthy subjects and postmenopausal osteoporotic women
18天前
已完结
Phase 3 study comparing the efficacy and safety of proposed biosimilar RGB-14-P with denosumab in postmenopausal women with osteoporosis: results from the transition (switch) phase
18天前
已完结
A systematic review of combination treatment strategies for osteoporosis
1个月前
已完结
Evaluating the Clinical Efficacy of Teriparatide and Denosumab Combination Therapy in Postmenopausal Osteoporosis: A Systematic Review and Meta-Analysis
1个月前
已关闭
Comparative Resistance to Teriparatide-Induced Bone Resorption With Denosumab or Alendronate
1个月前
已完结
皖公网安备34019202002308
